Global pharmaceutical firm Eli Lilly and Co. will invest $3.5 billion to build a manufacturing plant in Upper Macungie Township that is expected to create 850 jobs. “This is the largest single project ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The state is providing $100 ...
Orforglipron is a promising weight loss pill that could be a huge growth catalyst for Eli Lilly. The Food and Drug Administration has pushed back the target action date on the drug by nearly two weeks ...
Mock up of Eli Lilly's manufacturing site in the Lehigh Valley (Eli Lilly/Cision) Eli Lilly is expanding its footprint in eastern Pennsylvania with a new manufacturing site outside of Philadelphia.
I n what will be the largest single investment in Lehigh Valley history — and the largest life sciences project in Pennsylvania history — Eli Lilly and Company will invest $3.5 billion in a new ...
Eli Lilly (LLY 1.51%) has behaved more like a tech stock in recent years than like a pharma stock. Tech players are known to soar in the double and triple digits when the environment and corporate ...
Eli Lilly (LLY) enters 2026 facing uncertainties in GLP-1 market pricing and competitive dynamics, prompting a HOLD/neutral rating. Lilly's international growth, especially for Monujaro, may slow as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results